Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$462.2M
141M shares
52-week range
$2.39 – $4.43
49% from low
Sector
SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Exchange
NYSE
CS
Borrow rate
0.71%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.15B | $13.21B | $11.79B | $12.37B | $12.21B | $12.49B | $12.63B | $12.48B |
| Cost of revenue | $8.74B | $8.10B | $7.37B | $7.28B | $7.30B | $7.41B | $7.36B | $11.40B |
| Gross profit | $5.42B | $5.11B | $4.42B | $5.08B | $4.91B | $5.08B | $5.27B | $1.08B |
| Gross margin | 38.3% | 38.7% | 37.5% | 41.1% | 40.2% | 40.7% | 41.7% | 8.7% |
| R&D | $0 | $0 | $0 | $108.0M | $85.0M | $80.0M | $0 | $0 |
| Operating income | $208.0M | $650.0M | $1.13B | $1.40B | $821.0M | $957.0M | $542.0M | −$9.91B |
| EBITDA | $1.45B | $1.39B | $1.01B | $1.71B | $1.17B | $1.29B | $1.25B | $2.02B |
| Net income | −$788.0M | −$590.0M | $511.0M | $230.0M | $46.0M | −$133.0M | −$516.0M | $509.0M |
| Net margin | -5.6% | -4.5% | 4.3% | 1.9% | 0.4% | -1.1% | -4.1% | 4.1% |
| EPS (diluted) | -6.99 | -5.19 | 4.38 | 1.76 | 0.35 | -1.02 | -3.90 | 3.77 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11.6B | $-0.60 | $-0.96–$-0.25 | 3 |
| 2027 | $11.8B | $0.11 | $-0.03–$0.25 | 4 |
| 2028 | $11.9B | $0.09 | $0.08–$0.09 | 1 |
| 2029 | $14.6B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.
www.chs.netNo one on the platform currently holds CYH.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 467,793 | $1.5M |
No one on the platform has traded CYH yet.
| $707M |
| — |
| FDMT4D Molecular Therapeutics, Inc. | $12.88 | +11.03% | $673M | — |
| INNVInnovage Holding Corp. | $11.61 | +7.60% | $1.6B | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CYH Up 12% in a month. Not bad! $4-$5-$6 incoming. 💋 Is Ebola or Hantavirus or Ticks the current fear? I can't keep up. But all will be good for this lil gem 💎.
View on StockTwits ↗$CYH HOUSTON ... we have liftoff! 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀 🚀
View on StockTwits ↗$CYH Covid Proof ✅️ Ebola Proof ✅️ Gates/Fauci Proof ✅️
View on StockTwits ↗$AIM If you peeps truly believe Ebola is on its way to the states, then you should have bought $CYH instead. They have the hospital beds that will be needed, and would have the federal governments support. 💋
View on StockTwits ↗$CYH It's time to let this go. Get real. Take it to $5+, then to $10.
View on StockTwits ↗$CYH So, ahhh, if Covid sent this from $3.X to $15 , how high does Hantavirus send it? We really need Fauci and Gates opinions. And Fauci should be able to tell us if the Obama/Biden administrations were funding research into this.
View on StockTwits ↗$CYH RIPPIN’ haha just joking I will probably jinx it
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at NaN× earnings vs its 7.3× historical median P/E.
Fair value ≈ $-26.78 · price $3.39 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.